- Home
- LIME vs OCS Comparison
LIME vs OCS Comparison
Compare LIME & OCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$28.58
HOLD
Current Price
$11.13
Company Overview
Basic Information| Metric | LIME | OCS |
|---|---|---|
| Founded | N/A | 2003 |
| Country | United States | Switzerland |
| Employees | N/A | 60 |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.8B |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | LIME | OCS |
|---|---|---|
| Price | $28.58 | $11.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $42.00 |
| AVG Volume (30 Days) | 241.3K | ★ 367.2K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $466.06 |
| Revenue Next Year | N/A | $479.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.87 | $10.52 |
| 52 Week High | $27.31 | $34.48 |
Technical Indicators
Market Signals| Indicator | LIME | OCS |
|---|---|---|
| Relative Strength Index (RSI) | 69.93 | 30.14 |
| Support Level | N/A | $10.52 |
| Resistance Level | N/A | $21.79 |
| Average True Range (ATR) | 1.32 | 0.69 |
| MACD | 0.24 | 0.07 |
| Stochastic Oscillator | 96.16 | 6.35 |
Price Performance
Historical Comparison LIME
OCS
About OCS Oculis Holding AG Ordinary shares
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.